This page is an English translation of the Korean original. If there is any discrepancy, the Korean version prevails.

Congenital Malformation of Coronary Vessels관상동맥 기형

📋 Contents and key points
ItemDetails
A. Classification codesICD-10: Q24.5 | Special Copayment Reduction: V148 (rare disease)
B. SynonymsMalformation of coronary vessels | Congenital coronary artery aneurysm
C. Adult onsetLikelihood of first onset in adulthood low to moderate — mild anomalies of coronary artery origin may be found incidentally on cardiac examinations (CT, MRI) in adulthood. However, forms with exercise-induced myocardial ischemia sometimes first present as syncope or sudden death in childhood or adolescence.
1. History1886: Brooks first described anomalous origin of a coronary artery; diagnoses surged after the introduction of CT coronary angiography.
2. CausesAnomalies of coronary artery origin (anomalous origin, ALCAPA), coronary artery fistula (CAF), congenital coronary artery aneurysm, interarterial course.
3. GeneticsMostly sporadic; some associated with connective tissue disorders (Marfan, Ehlers-Danlos); genes associated with accompanying cardiac malformations.
4. General epidemiologyCoronary artery anomalies in about 1–2% of the total population; clinically significant anomalies about 0.3–0.5%; ALCAPA about 1:300,000.
5. PathophysiologyDepending on the form, the main mechanisms are ischemia (ALCAPA, interarterial course), shunting (CAF), and thrombosis (coronary artery aneurysm).
6. SymptomsALCAPA: heart failure in infancy; interarterial course: exercise-induced syncope and sudden death; CAF: heart murmur, ischemia; coronary artery aneurysm: myocardial infarction.
7. SignsALCAPA: findings of left ventricular dysfunction; CAF: continuous murmur; anomalous origin: normal physical findings are common.
8. ScreeningCardiac screening of athletes (including echocardiography); cardiac CT when anomalous origin is suspected; ALCAPA: in infants with heart failure.
9. DiagnosisCardiac CT coronary angiography is the standard; echocardiography for diagnosing ALCAPA and CAF; nuclear medicine and MRI for ischemia assessment.
10. TreatmentALCAPA: early surgical reimplantation; interarterial course: surgical correction when ischemia is confirmed; CAF: transcatheter or surgical closure.
11. PrognosisALCAPA: good recovery of left ventricular function after surgery; interarterial course: reduced risk of sudden death after correction; CAF: good after closure.
12. PreventionCardiac screening of athletes; early diagnosis of ALCAPA; antithrombotic therapy for coronary artery fistula; endocarditis prevention.
13. References10 major clinical guidelines and original papers

1. History

Congenital anomalies of coronary arteries (CAA) are anatomically highly diverse and encompass a broad spectrum from clinically harmless variants to high-risk anomalies that cause sudden death. In 1886, Brooks first described anomalous origin of a coronary artery, and later several anatomists reported various coronary artery anomalies at autopsy.

Its clinical importance was fully recognized in 1974, when Bland-White-Garland syndrome (anomalous left coronary artery from the pulmonary artery, ALCAPA) was established as a major cause of sudden infant death. In the 1980s–90s, anomalous origin of the coronary arteries and interarterial course drew attention as causes of sudden death in young athletes. With the spread of cardiac CT coronary angiography in the 2000s, diagnoses of coronary artery anomalies surged, and research on their clinical significance also became active.

Congenital coronary artery aneurysm (CAA) is a separate clinical entity; unlike coronary artery aneurysms after Kawasaki disease, it is an anomaly in which a coronary artery is congenitally focally dilated. In Korea, it is managed under Special Copayment Reduction (V148), and follow-up at a specialized cardiac center is needed.


2. Causes

Congenital coronary artery anomalies have various causal mechanisms depending on the anatomical type.

Anomalous origin of coronary artery: ① ALCAPA (Anomalous Left Coronary Artery from Pulmonary Artery): an anomaly in which the left coronary artery arises from the pulmonary artery; it is the most important cause of myocardial ischemia in infancy. As pulmonary artery pressure falls after birth, perfusion of the left coronary artery decreases and myocardial ischemia develops. ② Anomalous aortic origin with interarterial course: the coronary artery arises from the opposite aortic sinus and passes between the aorta and pulmonary artery. During exercise, dilation of the great vessels compresses the coronary artery, causing ischemia. It is a major cause of sudden death in young athletes.

Coronary artery fistula (CAF): the coronary artery connects directly to an atrium, ventricle, pulmonary artery, coronary sinus, or the like, so that coronary blood flow forms a shunt. Myocardial ischemia may develop due to coronary steal, and there is a risk of endocarditis, thrombosis, and coronary artery aneurysm formation.

Congenital coronary artery aneurysm: focal dilation of a coronary artery; the main complication is myocardial infarction due to thrombus formation and distal embolism.


3. Genetics

Most congenital coronary artery anomalies occur sporadically, and no specific causative gene has been established. Embryologically, anomalies of coronary artery origin and course are explained as abnormalities in the process by which the coronary primordia connect to the aorta.

The risk of coronary artery aneurysm is increased in connective tissue disorders (Marfan syndrome FBN1, Ehlers-Danlos syndrome COL3A1/COL5A1). When a congenital coronary artery anomaly accompanies other congenital heart malformations (tetralogy of Fallot, transposition of the great arteries, pulmonary atresia, etc.), the genetic cause of that malformation may be shared.

Coronary artery aneurysms after Kawasaki disease are not congenital, and ITPKC and CASP3 gene polymorphisms are associated with susceptibility to Kawasaki disease. Because the pathophysiology differs from congenital coronary artery aneurysm, differentiation is important.


4. General epidemiology

In large studies based on cardiac CT coronary angiography, the overall frequency of coronary artery anomalies is reported at about 1–2%. Most are clinically harmless variants (honeycomb-type origin, single coronary artery, etc.), and clinically significant anomalies are about 0.3–0.5%.

ALCAPA (Bland-White-Garland syndrome) is very rare, with a frequency of about 1:300,000 births, but infant mortality is high without treatment. Coronary artery fistula (CAF) accounts for about 0.2–0.4% of congenital heart malformations. Interarterial course of an anomalously arising coronary artery is the second most common cause of sudden death in young athletes (after hypertrophic cardiomyopathy).

In Korea, incidental detection of coronary artery anomalies has been increasing since cardiac CT became widespread, and they are managed under V148 Special Copayment Reduction registration.


5. Pathophysiology

The pathophysiology of congenital coronary artery anomalies is broadly divided into three mechanisms according to the anatomical type.

Ischemic mechanism (ALCAPA): when pulmonary artery pressure falls normally after birth, the perfusion pressure to the left coronary artery arising from the pulmonary artery decreases. Hypoxic pulmonary arterial blood enters the left coronary artery, and further, a 'steal phenomenon' occurs in which left coronary blood flow reverses into the pulmonary artery, causing severe left ventricular myocardial ischemia. Myocardial ischemia → left ventricular dysfunction → heart failure progresses rapidly in infancy.

Ischemic mechanism (interarterial course): during exercise, increased cardiac output and dilation of the aorta and pulmonary artery compress the coronary artery running between the two great vessels, causing myocardial ischemia. Anomalous origin of the left main coronary artery (LM) or right coronary artery (RCA) in particular is the main form causing sudden death.

Shunt mechanism (coronary artery fistula): blood flow is diverted through a direct connection between the coronary artery and a cardiac chamber or the pulmonary artery, reducing blood flow to the distal myocardium (coronary steal). The larger the fistula, the greater the shunt volume and the more severe the myocardial ischemia.

Thrombotic/embolic mechanism (coronary artery aneurysm): blood stasis in the dilated coronary artery leads to thrombus formation and distal embolism, causing myocardial infarction.


6. Symptoms

The symptoms of congenital coronary artery anomalies vary greatly according to anatomical type and severity.

ALCAPA (infancy): at 2–12 months of age, excessive sweating, pallor, feeding refusal, and respiratory distress appear during feeding. This corresponds to ischemic chest pain when myocardial oxygen demand increases with the exertion of feeding. Heart failure progresses rapidly due to left ventricular dysfunction from myocardial ischemia.

Anomalous origin with interarterial course (childhood to adolescence): chest pain, dizziness, and syncope occur during exercise. The most dangerous first presentation is sudden cardiac death, typically occurring during competitive sports. In some cases, sudden death is the first presentation without prior symptoms.

Coronary artery fistula (childhood to adulthood): mild cases are discovered as a heart murmur without symptoms. With a large fistula, exercise intolerance, fatigue, and palpitations appear. Rarely, endocarditis, coronary artery aneurysm, or fistula rupture occurs.

Congenital coronary artery aneurysm: mostly asymptomatic, but when myocardial infarction (thromboembolism) or angina develops, chest pain is the main symptom.


7. Signs

ALCAPA: a mitral regurgitation murmur may be heard on auscultation (functional MR due to left ventricular dilation). Left ventricular dysfunction produces S3, tachycardia, and tachypnea. Anterolateral myocardial infarction or ischemic findings (Q waves, ST changes) on ECG in an infant strongly suggest ALCAPA.

Coronary artery fistula (CAF): a characteristic continuous murmur is heard on auscultation. It resembles patent ductus arteriosus (PDA) on auscultation, but the location of the murmur differs. The larger the fistula, the more prominent the murmur.

Anomalous origin with interarterial course: physical findings at rest are often normal, so clinical suspicion is key. It must be ruled out in young athletes with a history of exercise-induced syncope or chest pain.

Congenital coronary artery aneurysm: normal physical findings at rest are common. When complicated by myocardial infarction, findings of ischemic changes appear.


8. Screening

Screening for heart failure in infancy: ALCAPA must be ruled out in infants aged 2–12 months with heart failure symptoms (feeding difficulty, sweating, pallor). If ECG shows anterolateral ischemic findings, echocardiography and cardiac CT are performed immediately.

Screening of athletes: in young competitive athletes with exercise-induced symptoms (syncope, chest pain, palpitations) or a family history of sudden death, echocardiography is performed, and cardiac CT is added if the coronary artery origin is unclear. Some countries, such as Italy and the United States, have institutionalized pre-participation screening of athletes (ECG, echocardiography).

Incidental findings on cardiac CT: coronary artery anomalies are increasingly discovered incidentally on cardiac CT performed for other reasons. Additional evaluation (ischemia imaging, cardiac MRI, etc.) is needed to assess clinical significance.


9. Diagnosis

Echocardiography: in the diagnosis of ALCAPA, it confirms the origin of the left coronary artery (from the pulmonary artery) and evaluates left ventricular function. In coronary artery fistula, color Doppler confirms the location and flow of the fistula. When visualization of the coronary artery origin is insufficient, it is supplemented with cardiac CT.

Cardiac CT coronary angiography (CCTA): the standard for diagnosing coronary artery anomalies. High-resolution 3D reconstruction precisely identifies the coronary artery origin, course, and relationship to the great vessels. It evaluates whether there is an interarterial course, the size of coronary artery aneurysms, and the connection sites of fistulas.

Cardiac MRI/nuclear imaging (SPECT, PET): evaluates the extent and severity of ischemia. In interarterial course, the presence or absence of exercise-induced ischemia is important for the surgical decision.

Cardiac catheterization and coronary angiography: invasive, but used to determine fistula size, hemodynamics, and anatomical details before surgery.


10. Treatment

ALCAPA: surgical coronary artery reimplantation or left coronary artery reconstruction is required immediately upon diagnosis. Medical stabilization (diuretics, ACE inhibitors, dobutamine) is provided until surgery. After successful surgery, left ventricular function recovers over months to years.

Anomalous origin with interarterial course: when ischemia is confirmed, surgical correction (coronary artery reimplantation, creation of an unobstructed course, unroofing of the aortic sinus, etc.) is recommended. Management strategy is controversial when ischemia is not confirmed and the patient is asymptomatic, but there is a tendency to recommend prophylactic surgery in young athletes.

Coronary artery fistula (CAF): for large fistulas (Qp/Qs > 1.5, symptoms, ischemia), transcatheter closure (coils or plugs) or surgical ligation is performed. Because spontaneous closure can occur in some children, follow-up observation is preferred in mild cases.

Congenital coronary artery aneurysm: thrombosis prevention with antiplatelet or anticoagulant therapy. Surgical treatment is considered for giant aneurysms (diameter >8mm) or thrombus formation.


11. Prognosis

ALCAPA: after early surgical correction, left ventricular function recovers to normal or near normal over months to years in most patients. The 10-year survival after surgery is over 90%. However, in some, left ventricular function may not fully recover due to irreversible myocardial fibrosis.

Anomalous origin with interarterial course: the risk of sudden death is reported to decrease markedly after surgical correction. Resumption of exercise is decided by specialist cardiology evaluation after surgery.

Coronary artery fistula: after transcatheter or surgical closure, ischemia and shunt-related symptoms resolve. Because recurrence is possible, follow-up cardiac CT or echocardiography is needed.

Congenital coronary artery aneurysm: with appropriate antithrombotic therapy and regular follow-up, most show a stable course. With large aneurysms, the risk of myocardial infarction persists.


12. Prevention

Primary prevention of congenital coronary artery anomalies is not possible.

Early diagnosis: for ALCAPA, immediate differentiation in infantile heart failure is decisive for survival. When exercise-induced symptoms occur in athletes, cardiac CT evaluation is performed immediately.

Pre-participation screening of athletes: ECG and echocardiography screening before participation in competitive sports detects high-risk cardiac abnormalities, including anomalous origin of the coronary arteries.

Antithrombotic therapy: prevention of thrombus formation with aspirin or anticoagulants in patients with congenital coronary artery aneurysm.

Exercise restriction: participation in competitive sports is prohibited in patients with anomalous origin with interarterial course before correction.

Prevention of infective endocarditis: prophylactic antibiotics before invasive procedures in high-risk patients with coronary artery fistula.


13. References

  1. Yamanaka O, Hobbs RE. Coronary artery anomalies in 126,595 patients undergoing coronary arteriography. Cathet Cardiovasc Diagn. 1990;21(1):28-40. PMID: 2208265.

  2. Bland EF, White PD, Garland J. Congenital anomalies of the coronary arteries: report of an unusual case associated with cardiac hypertrophy. Am Heart J. 1933;8(6):787-801.

  3. Baumgartner H, De Backer J, Babu-Narayan SV, et al. 2020 ESC Guidelines for adult congenital heart disease. Eur Heart J. 2021;42(6):563-645. DOI: 10.1093/eurheartj/ehaa554. PMID: 32860028.

  4. Warnes CA, Williams RG, Bashore TM, et al. ACC/AHA 2008 Guidelines for Adults with Congenital Heart Disease. J Am Coll Cardiol. 2008;52(23):e143-e263. PMID: 19038677.

  5. Maron BJ, Doerer JJ, Haas TS, Tierney DM, Mueller FO. Sudden deaths in young competitive athletes: analysis of 1866 deaths in the United States, 1980–2006. Circulation. 2009;119(8):1085-1092. DOI: 10.1161/CIRCULATIONAHA.108.804617. PMID: 19221222.

  6. Brothers JA, Frommelt MA, Jaquiss RDB, Myerburg RJ, Fraser CD Jr, Tweddell JS. Expert consensus guidelines: anomalous aortic origin of a coronary artery. J Thorac Cardiovasc Surg. 2017;153(6):1440-1457. DOI: 10.1016/j.jtcvs.2016.06.058. PMID: 28527753.

  7. Gowda RM, Vasavada BC, Khan IA. Coronary artery fistulas: clinical and therapeutic considerations. Int J Cardiol. 2006;107(1):7-10. DOI: 10.1016/j.ijcard.2005.02.039. PMID: 16364481.

  8. Tsuda E, Miyazaki S. Diagnosis and management of anomalous origin of the left coronary artery from the pulmonary artery. Pediatr Int. 2016;58(6):450-457. DOI: 10.1111/ped.12921. PMID: 26756688.

  9. Hoffman JI, Kaplan S. The incidence of congenital heart disease. J Am Coll Cardiol. 2002;39(12):1890-1900. PMID: 12084585.

  10. Cheezum MK, Liberthson RR, Shah NR, et al. Anomalous aortic origin of a coronary artery from the inappropriate sinus of Valsalva. J Am Coll Cardiol. 2017;69(12):1592-1608. DOI: 10.1016/j.jacc.2017.01.031. PMID: 28335835.